Table 2.
Overview of Strength of Evidence for Beneficial Effects of the Ketogenic Diet for Cancer and Related Outcomes in Pre-Clinical and Clinical Studies.
| Strength of Evidence | ||||
|---|---|---|---|---|
| Strong | Moderate | Weak | Unknown | |
| Pre-Clinical Studies | ||||
| Tumor weight | X | |||
| Antitumor effect/Tumor growth | X | |||
| Progression-free survival | X | |||
| Tumor volume | X | |||
| Overall survival time | X | |||
| Cells’ responsiveness to therapy | X | |||
| Body composition | X | |||
| Clinical Studies as an Adjunctive Therapy | ||||
| Tumor weight | X | |||
| Antitumor effect/Tumor growth | X | |||
| Progression-free survival | X | |||
| Tumor volume | X | |||
| Overall survival time | X | |||
| Cells’ responsiveness to therapy | X | |||
| Quality of life | X | |||
| Body composition | X | |||